Ástralía -
enska -
Department of Health (Therapeutic Goods Administration)
kytril granisetron (as hydrochloride) 3mg/ 3ml injection ampoule
atnahs pharma australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; sodium chloride; water for injections; sodium hydroxide - adults: kytril (tablets and injection) is indicated for use in adults for: the prevention of nausea and vomiting induced by cytotoxic chemotherapy; the prevention of nausea and vomiting induced by radiotherapy. kytril (injection) is also indicated for use in the treatment of nausea and vomiting induced by cytotoxic chemotherapy; and prevention and treatment of post-operative nausea and vomiting.,paediatric: kytril injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy..
Írland -
enska -
HPRA (Health Products Regulatory Authority)
kytril 1mg film-coated tablets
atnahs pharma uk limited - granisetron hydrochloride - film-coated tablet - 1 milligram(s) - serotonin (5ht3) antagonists; granisetron
Írland -
enska -
HPRA (Health Products Regulatory Authority)
kytril 2mg film-coated tablets
atnahs pharma uk limited - granisetron hydrochloride - film-coated tablet - 2 milligram(s) - serotonin (5ht3) antagonists; granisetron
Ísrael -
enska -
Ministry of Health
setron 1 mg
padagis israel agencies ltd, israel - granisetron as hydrochloride - tablets - granisetron as hydrochloride 1 mg - granisetron - granisetron - prevention of nausea and vomiting induced by cytostatic therapy.
Írland -
enska -
HPRA (Health Products Regulatory Authority)
kytril 1mg film-coated tablets
atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 1 milligram(s) - serotonin (5ht3) antagonists; granisetron
Írland -
enska -
HPRA (Health Products Regulatory Authority)
kytril 2mg film-coated tablets
atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 2 milligram(s) - serotonin (5ht3) antagonists; granisetron
Írland -
enska -
HPRA (Health Products Regulatory Authority)
granisetron teva 3 mg/3 ml concentrate for solutio 3/3 mg/ml concentrate for soln for inf
teva pharma b.v. - granisetron hydrochloride - concentrate for soln for inf - 3/3 mg/ml
Ísrael -
enska -
Ministry of Health
zofran tablets 8 mg
novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.
Ísrael -
enska -
Ministry of Health
zofran tablets 4 mg
novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.
Írland -
enska -
HPRA (Health Products Regulatory Authority)
granisetron teva 2 milligram film coated tablet
teva pharma b.v. - granisetron hydrochloride - film coated tablet - 2 milligram